Completed PHASE3 INTERVENTIONAL NCT00110968
Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia
A Multicentre, Open-label Extension Phase to Study the Long-term Safety and Efficacy of Itopride HCl in Patients Suffering From Functional Dyspepsia
Sponsor: Forest Laboratories
Conditions
Dyspepsia
Interventions
Itopride hydrochloride
Updated 1 time since 2024 Last updated: Feb 6, 2017 Started: Sep 30, 2004 Primary completion: Jul 31, 2006 Completion: Sep 30, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE3 clinical study on Dyspepsia, this trial is completed. The trial is conducted by Forest Laboratories and has accumulated 1 data snapshot since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Forest Laboratories
Data source: Forest Laboratories
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.